Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Resolution Therapeutics has raised $28.9M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Resolution Therapeutics's investors include Old College Capital, Syncona Partners LLP.
Resolution Therapeutics is headquartered in London, United Kingdom.
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Resolution Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resolution Therapeutics — Funding & Investors." VCBacked, October 3, 2024, https://www.vcbacked.co/company/resolution-therapeutics. Accessed September 16, 2026.
VCBacked. (2024). Resolution Therapeutics — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/resolution-therapeutics
{{cite web |title=Resolution Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resolution-therapeutics |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated